Breaking News Instant updates and real-time market news.

2019-08-19 09:06:28 MYOV Myovant Sciences $6.98 / -0.01 (-0.14%) 09:06 08/19/19 08/19 09:06 08/19/19 09:06	SVB Leerink bullish on Myovant Sciences, initiates with an Outperform As previously reported, SVB Leerink analyst Ami Fadia started coverage of Myovant Sciences with an Outperform and a $26 price target. The analyst notes that Myovant's lead product relugolix is poised to become the second gonadotropin releasing hormone antagonist for treating endometriosis and uterine fibroids, and maintains her positive outlook on the GnRH antagonists market, which she believes could grow to over $4.5B in sales in 2025 and support multiple products. While Fadia acknowledges that expectations for Myovant have been reset following the recent relugolix Phase 3 data in UF, which may have been disappointing relative to expectations for a best-in-class profile, at current levels she believes the market underestimates relugolix's $1B sales potential in 2025 based on its tolerability profile and convenient dosing regimen.
MYOV Myovant Sciences $6.98 / -0.01 (-0.14%) 08/19/19 SVB Leerink Myovant Sciences initiated with an Outperform at SVB Leerink 05/30/19 Citi Myovant Sciences assumed with a Buy at Citi 05/29/19 JPMorgan Myovant Sciences shares oversold at current levels, says JPMorgan 05/14/19 Barclays Myovant Sciences selloff overdone after report of relugolix data, says Barclays

2019-08-19 09:06:28

MYOV

Myovant Sciences

$6.98 / -0.01 (-0.14%)

09:06

08/19/19

08/19

09:06

08/19/19

09:06

SVB Leerink bullish on Myovant Sciences, initiates with an Outperform

As previously reported, SVB Leerink analyst Ami Fadia started coverage of Myovant Sciences with an Outperform and a $26 price target. The analyst notes that Myovant's lead product relugolix is poised to become the second gonadotropin releasing hormone antagonist for treating endometriosis and uterine fibroids, and maintains her positive outlook on the GnRH antagonists market, which she believes could grow to over $4.5B in sales in 2025 and support multiple products. While Fadia acknowledges that expectations for Myovant have been reset following the recent relugolix Phase 3 data in UF, which may have been disappointing relative to expectations for a best-in-class profile, at current levels she believes the market underestimates relugolix's $1B sales potential in 2025 based on its tolerability profile and convenient dosing regimen.

MYOV Myovant Sciences

$6.98 / -0.01 (-0.14%)

08/19/19 SVB Leerink: Myovant Sciences initiated with an Outperform at SVB Leerink

05/30/19 Citi: Myovant Sciences assumed with a Buy at Citi

05/29/19 JPMorgan: Myovant Sciences shares oversold at current levels, says JPMorgan

05/14/19 Barclays: Myovant Sciences selloff overdone after report of relugolix data, says Barclays

TODAY'S FREE FLY STORIES

Hot Stocks	Congressman Ryan joins call for USPS order with Oshkosh to be overturned » 15:22 03/02/21 03/02 15:22 03/02/21 15:22 WKHS Workhorse Group $15.95 / -1.385 (-7.99%) , OSK Oshkosh $108.27 / -2.255 (-2.04%) Congressman Tim Ryan of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WKHS OSK WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 03/01/21 Workhorse Group has scheduled a face-to-face meeting with USPS on March 3 03/01/21 Workhorse Group CEO says entering 2021 in 'strongest-ever position' 02/25/21 Workhorse up 20% after congressman vows to fight Oshkosh award from USPS 02/25/21 Workhorse Group trading resumes OSK Oshkosh $108.27 / -2.255 (-2.04%) 02/25/21 Workhorse up 20% after congressman vows to fight Oshkosh award from USPS 02/24/21 Ford up 1% in pre-market trading after yesterday's USPS win by Oshkosh 02/23/21 Oshkosh confirms selection to produce USPS Next Generation Delivery Vehicle 02/23/21 Oshkosh up 8% after winning USPS contract WKHS OSK WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 02/24/21 Fly Intel: Top five analyst downgrades 02/24/21 Oppenheimer Opco downgrades Workhorse after Postal Service snub despite backlog 02/24/21 Roth Capital Roth cuts Workhorse target to $15 after 'highly unusual' contract loss 02/24/21 Oppenheimer Workhorse Group downgraded to Perform from Outperform at Oppenheimer OSK Oshkosh $108.27 / -2.255 (-2.04%) 02/24/21 Evercore ISI Oshkosh price target raised to $133 from $120 at Evercore ISI 02/24/21 KeyBanc Oshkosh price target raised to $125 from $104 at KeyBanc 02/24/21 Oppenheimer Opco downgrades Workhorse after Postal Service snub despite backlog 02/24/21 Roth Capital Roth cuts Workhorse target to $15 after 'highly unusual' contract loss WKHS OSK WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 03/01/21 Workhorse Group reports Q4 revenue $652,000, consensus $1.32M 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M OSK Oshkosh $108.27 / -2.255 (-2.04%) 01/27/21 Oshkosh reports Q1 adjusted EPS $1.13, consensus 73c 10/29/20 Oshkosh reports Q4 adjusted EPS $1.30, consensus $1.09 WKHS OSK WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 02/25/21 House Democrat vows to stop USPS contract with Oshkosh, Bloomberg says 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 12/02/20 USPS again delays mail truck replacement contract, Trucks.com reports OSK Oshkosh $108.27 / -2.255 (-2.04%) 02/25/21 House Democrat vows to stop USPS contract with Oshkosh, Bloomberg says 02/24/21 Ford may not have a piece of Oshkosh-USPS contract, Detroit Free Press reports 12/02/20 USPS again delays mail truck replacement contract, Trucks.com reports WKHS OSK WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/24/21 Workhorse plunges, asks USPS for more info after NGDV deal goes to Oshkosh OSK Oshkosh $108.27 / -2.255 (-2.04%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/24/21 Workhorse plunges, asks USPS for more info after NGDV deal goes to Oshkosh 04/28/21 Oshkosh - OSK WKHS WKHS Workhorse Group $15.95 / -1.385 (-7.99%) 02/04/21 Workhorse Group call volume above normal and directionally bullish 01/28/21 Largest borrow rate increases among liquid names 01/26/21 Workhorse Group call volume above normal and directionally bullish 01/26/21 Unusually active option classes on open January 26th
Recommendations	EssilorLuxottica price target raised to EUR 133 from EUR 121 at UBS » 15:20 03/02/21 03/02 15:20 03/02/21 15:20 ESLOY EssilorLuxottica $0.00 / + (+0.00%) UBS analyst Susy Tibaldi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ESLOY EssilorLuxottica $0.00 / + (+0.00%) 12/17/20 EssilorLuxottica declares interim dividend for FY20 of EUR 1.15 per share 12/17/20 EssilorLuxottica appoints Francesco Milleri as CEO, announces other changes ESLOY EssilorLuxottica $0.00 / + (+0.00%) 02/17/21 Stifel EssilorLuxottica downgraded to Hold from Buy at Stifel 02/11/21 RBC Capital EssilorLuxottica price target raised to EUR 146 from EUR 140 at RBC Capital 01/19/21 Societe Generale EssilorLuxottica downgraded to Sell from Hold at Societe Generale 10/20/20 UBS EssilorLuxottica price target raised to EUR 121 from EUR 119 at UBS ESLOY EssilorLuxottica $0.00 / + (+0.00%) 11/03/20 EssilorLuxottica reports Q3 revenue EUR 4.085B, down 5.2% y/y
Recommendations	Erste Group Bank price target raised to EUR 31 from EUR 30 at UBS » 15:19 03/02/21 03/02 15:19 03/02/21 15:19 EBKDY Erste Group Bank $0.00 / + (+0.00%) UBS analyst Mate Nemes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EBKDY Erste Group Bank $0.00 / + (+0.00%) 15:04 Today Deutsche Bank Erste Group Bank price target raised to EUR 25 from EUR 24 at Deutsche Bank 03/01/21 Morgan Stanley Erste Group Bank price target raised to EUR 30 from EUR 26 at Morgan Stanley 02/08/21 UBS Erste Group Bank price target raised to EUR 30 from EUR 29 at UBS 02/01/21 Credit Suisse Erste Group Bank initiated with a Neutral at Credit Suisse
Options	KemPharm options imply 59.3% move in share price post-earnings » 15:19 03/02/21 03/02 15:19 03/02/21 15:19 KMPH KemPharm $9.14 / -0.65 (-6.64%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options KMPH KemPharm $9.14 / -0.65 (-6.64%) 01/27/21 KemPharm announces FDA approval of IND for KP879 01/14/21 KemPharm announces presentations on KP415, serdexmethylphenidate 12/23/20 KemPharm announces 1-for-16 reverse stock split 12/22/20 KemPharm files IND for KP879 for treatment of stimulant use disorder KMPH KemPharm $9.14 / -0.65 (-6.64%) 01/25/21 Roth Capital KemPharm initiated with a Buy at Roth Capital 05/20/20 H.C. Wainwright KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright 00:00 Today PDUFA Date for KP415 KMPH KemPharm $9.14 / -0.65 (-6.64%) 02/25/21 Largest borrow rate increases among liquid names 01/21/21 Eighteen new option listings and one option delisting on January 21st 12/21/20 Four new option listings and fifteen option delistings on December 21st
Recommendations	EQT AB price target raised to SEK 240 from SEK 178 at UBS » 15:17 03/02/21 03/02 15:17 03/02/21 15:17 EQBBF EQT AB $0.00 / + (+0.00%) UBS analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EQBBF EQT AB $0.00 / + (+0.00%) 11/24/20 Morgan Stanley EQT AB price target raised to SEK 199 from SEK 180 at Morgan Stanley 09/10/20 Morgan Stanley EQT AB price target lowered to SEK 175 from SEK 195 at Morgan Stanley 07/17/20 JPMorgan EQT AB price target raised to SEK 163 from SEK 128 at JPMorgan 07/17/20 Goldman Sachs EQT AB price target raised to SEK 165 from SEK 145 at Goldman Sachs

Technical Analysis	NASDAQ market internals summary » 15:17 03/02/21 03/02 15:17 03/02/21 15:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 15:16 03/02/21 03/02 15:16 03/02/21 15:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary
Recommendations	Logitech price target raised to CHF 121 from CHF 116 at Credit Suisse » 15:12 03/02/21 03/02 15:12 03/02/21 15:12 LOGI Logitech $107.96 / +0.54 (+0.50%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LOGI Logitech $107.96 / +0.54 (+0.50%) 01/19/21 Logitech CEO: We're going to be right in the center of how people work 01/18/21 Logitech does not expect level of margin expansion to sustain 11/15/20 Fly Intel: Top five weekend stock stories 10/20/20 Logitech CEO: It was a great quarter LOGI Logitech $107.96 / +0.54 (+0.50%) 09:24 Today DA Davidson Logitech price target raised to $135 from $119 at DA Davidson 02/22/21 UBS Logitech price target raised to CHF 108 from CHF 90 at UBS 02/10/21 DA Davidson Corsair Gaming price target raised to $52 from $33 at DA Davidson 01/21/21 UBS Logitech price target raised to CHF 90 from CHF 74 at UBS LOGI Logitech $107.96 / +0.54 (+0.50%) 03/01/21 Logitech sees FY22 revenue flat +/- 5%, consensus $4.47B 03/01/21 Logitech raises FY21 revenue view to up 63% from up 57%-60%, consensus $4.8B 01/18/21 Logitech raises FY21 sales growth outlook to 57%-60% from 35%-40% 01/18/21 Logitech reports Q3 EPS $2.45, consensus $1.02 LOGI Logitech $107.96 / +0.54 (+0.50%) 11/14/20 Logitech business already booming before COVID, Barron's says 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 09/26/20 TVs getting left behind as videoconferencing booms, Barron's says LOGI Logitech $107.96 / +0.54 (+0.50%) 03/01/21 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday LOGI Logitech $107.96 / +0.54 (+0.50%) 01/05/21 Largest borrow rate increases among liquid names 12/24/20 Largest borrow rate increases among liquid names 11/09/20 Logitech put volume heavy and directionally bearish 10/28/20 Logitech put volume heavy and directionally bearish
Recommendations	Anadolu Efes price target raised to TRY 37.10 from TRY 36.70 at Credit Suisse » 15:11 03/02/21 03/02 15:11 03/02/21 15:11 AEBZY Anadolu Efes $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AEBZY Anadolu Efes $0.00 / + (+0.00%) 11/25/20 JPMorgan Anadolu Efes upgraded to Overweight from Neutral at JPMorgan 05/22/20 JPMorgan Anadolu Efes price target lowered to TRY 22 from TRY 29.11 at JPMorgan
Recommendations	Acerinox price target raised to EUR 10 from EUR 9.50 at Credit Suisse » 15:11 03/02/21 03/02 15:11 03/02/21 15:11 ANIOY Acerinox $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ANIOY Acerinox $0.00 / + (+0.00%) 03/01/21 Deutsche Bank Acerinox price target raised to EUR 14 from EUR 13 at Deutsche Bank 02/02/21 Morgan Stanley Aperam downgraded to Equal Weight from Overweight at Morgan Stanley 02/02/21 Morgan Stanley Acerinox upgraded to Overweight from Equal Weight at Morgan Stanley 01/25/21 JPMorgan Acerinox price target raised to EUR 11.40 from EUR 9 at JPMorgan

Recommendations	Grifols price target lowered to EUR 24 from EUR 26 at Credit Suisse » 15:10 03/02/21 03/02 15:10 03/02/21 15:10 GRFS Grifols $16.29 / -0.18 (-1.09%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GRFS Grifols $16.29 / -0.18 (-1.09%) 01/28/21 Grifols announces publication of article on Phase 2 clinical trial of GRF6019 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M GRFS Grifols $16.29 / -0.18 (-1.09%) 14:55 Today JPMorgan Grifols price target lowered to EUR 23 from EUR 26.50 at JPMorgan 02/12/21 Berenberg Grifols price target lowered to EUR 23 from EUR 24.50 at Berenberg 01/22/21 Barclays Grifols price target lowered to EUR 31 from EUR 32 at Barclays 01/20/21 Credit Suisse Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse
Recommendations	Lloyds Banking price target lowered to 42 GBp from 43 GBp at RBC Capital » 15:09 03/02/21 03/02 15:09 03/02/21 15:09 LYG Lloyds Banking $2.15 / -0.015 (-0.69%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options LYG Lloyds Banking $2.15 / -0.015 (-0.69%) 02/24/21 Lloyds Banking sees 2021 net interest margin in excess of 240 basis points 02/24/21 Lloyds Banking announces aims for Strategic Review 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 LYG Lloyds Banking $2.15 / -0.015 (-0.69%) 03/01/21 Deutsche Bank Lloyds Banking price target raised to 39 GBp from 38 GBp at Deutsche Bank 03/01/21 UBS Lloyds Banking price target raised to 45 GBp from 40 GBp at UBS 02/26/21 Berenberg Lloyds Banking price target raised to 38 GBp from 32 GBp at Berenberg 02/25/21 Societe Generale Lloyds Banking price target raised to 47 GBp from 42 GBp at Societe Generale LYG Lloyds Banking $2.15 / -0.015 (-0.69%) 02/24/21 Lloyds Banking reports 2020 EPS 1.2p vs. 3.5p last year 10/29/20 Lloyds Banking reports 9 months EPS 0.5p vs. 2.2p last year LYG Lloyds Banking $2.15 / -0.015 (-0.69%) 12:57 Today French bankers want new EU law to move euro clearing to Frankfurt, Reuters says LYG Lloyds Banking $2.15 / -0.015 (-0.69%) 02/22/21 Largest borrow rate increases among liquid names
Recommendations	Dufry price target raised to CHF 55 from CHF 45 at RBC Capital » 15:09 03/02/21 03/02 15:09 03/02/21 15:09 DUFRY Dufry $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events DUFRY Dufry $0.00 / + (+0.00%) 02/17/21 UBS Dufry price target raised to CHF 48 from CHF 35 at UBS 01/27/21 Goldman Sachs Dufry upgraded to Buy from Neutral at Goldman Sachs 11/17/20 RBC Capital Dufry initiated with an Underperform at RBC Capital 11/04/20 Oddo BHF Dufry downgraded to Neutral from Buy at Oddo BHF 03/09/21 Dufry - DUFRY
Recommendations	Johnson Matthey price target raised to 3,300 GBp at Deutsche Bank » 15:05 03/02/21 03/02 15:05 03/02/21 15:05 JMPLY Johnson Matthey $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research JMPLY Johnson Matthey $0.00 / + (+0.00%) 01/11/21 Johnson Matthey awarded multi-million pound agreement from SFC Energy 12/22/20 Johnson Matthey, Thyssenkrupp renew partnership for ammonia production 09/08/20 KBR, Johnson Matthey sign agreement for ammonia-methanol co-production process JMPLY Johnson Matthey $0.00 / + (+0.00%) 02/17/21 AlphaValue Johnson Matthey upgraded to Reduce from Sell at AlphaValue 02/05/21 Morgan Stanley Johnson Matthey price target raised to 3,500 GBp at Morgan Stanley 02/05/21 Barclays Johnson Matthey downgraded to Underweight from Equal Weight at Barclays 01/20/21 Berenberg Johnson Matthey price target raised to 3,200 GBp from 3,000 GBp at Berenberg
Recommendations	Eurofins Scientific price target raised to EUR 57 from EUR 55 at Deutsche Bank » 15:04 03/02/21 03/02 15:04 03/02/21 15:04 ERRFY Eurofins Scientific $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ERRFY Eurofins Scientific $0.00 / + (+0.00%) 02/11/21 Barclays Eurofins Scientific price target raised to EUR 90 from EUR 80 at Barclays 02/11/21 Morgan Stanley Eurofins Scientific upgraded to Equal Weight from Underweight at Morgan Stanley 01/27/21 Berenberg Eurofins Scientific price target raised to EUR 88 from EUR 83.50 at Berenberg 01/26/21 Credit Suisse Eurofins Scientific price target raised to EUR 80 from EUR 76 at Credit Suisse

Recommendations	Erste Group Bank price target raised to EUR 25 from EUR 24 at Deutsche Bank » 15:04 03/02/21 03/02 15:04 03/02/21 15:04 EBKDY Erste Group Bank $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EBKDY Erste Group Bank $0.00 / + (+0.00%) 03/01/21 Morgan Stanley Erste Group Bank price target raised to EUR 30 from EUR 26 at Morgan Stanley 02/08/21 UBS Erste Group Bank price target raised to EUR 30 from EUR 29 at UBS 02/01/21 Credit Suisse Erste Group Bank initiated with a Neutral at Credit Suisse 01/29/21 Deutsche Bank Erste Group Bank price target raised to EUR 24 from EUR 21 at Deutsche Bank
Options	Nordstrom options imply 13.1% move in share price post-earnings » 15:04 03/02/21 03/02 15:04 03/02/21 15:04 JWN Nordstrom $37.60 / -0.35 (-0.92%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JWN Nordstrom $37.60 / -0.35 (-0.92%) 03/01/21 Nordstrom, Tonal form partnership 02/04/21 Nordstrom turns negative, down 2% after issuing guidance 02/04/21 Nordstrom trading resumes 02/04/21 Nordstrom says 'focused on accelerating revenue growth, expanding profit margin' JWN Nordstrom $37.60 / -0.35 (-0.92%) 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan 02/10/21 Gordon Haskett Nordstrom upgraded to Buy from Hold at Gordon Haskett 01/21/21 Deutsche Bank Nordstrom price target raised to $43 from $24 at Deutsche Bank 01/14/21 Credit Suisse Nordstrom price target raised to $39 from $26 at Credit Suisse JWN Nordstrom $37.60 / -0.35 (-0.92%) 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually 02/04/21 Nordstrom sees 2021 revenue up more than 25%, EBIT positive 02/04/21 Nordstrom reiterates Q4 outlook, sees sales down low 20 percent range 11/24/20 Nordstrom sees Q4 sales down in the low 20% range, consensus $4.01B JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/14/21 Fly Intel: Pre-market Movers 01/13/21 Fly Intel: After-Hours Movers 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street 11/24/20 Fly Intel: After-Hours Movers 16:45 Today Nordstrom - JWN JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/29/21 Nordstrom put buyer realizes 156% same-day gains 01/25/21 Early notable gainers among liquid option names on January 25th 12/31/20 Early notable gainers among liquid option names on December 31st 12/30/20 Early notable gainers among liquid option names on December 30th
Recommendations	ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank » 15:03 03/02/21 03/02 15:03 03/02/21 15:03 ASMIY ASM International $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ASMIY ASM International $0.00 / + (+0.00%) 03/01/21 Barclays ASM International price target raised to EUR 250 from EUR 210 at Barclays 03/01/21 Credit Suisse ASM International price target raised to EUR 265 from EUR 250 at Credit Suisse 01/25/21 Credit Suisse ASM International price target raised to EUR 250 from EUR 204 at Credit Suisse 01/14/21 Barclays ASM International price target raised to EUR 210 from EUR 180 at Barclays
Recommendations	Vestas price target raised to DKK 1,350 from DKK 1,300 at Berenberg » 15:03 03/02/21 03/02 15:03 03/02/21 15:03 VWDRY Vestas $0.00 / + (+0.00%) Berenberg analyst Henry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VWDRY Vestas $0.00 / + (+0.00%) 02/26/21 BofA Vestas removed from Europe 1 list at BofA 02/25/21 UBS Vestas upgraded to Buy from Neutral at UBS 02/11/21 Deutsche Bank Vestas price target lowered to DKK 1,460 from DKK 1,500 at Deutsche Bank 02/08/21 Deutsche Bank Vestas price target lowered to DKK 1,500 from DKK 1,630 at Deutsche Bank
Recommendations	Rightmove price target raised to 455 GBp from 440 GBp at Berenberg » 15:02 03/02/21 03/02 15:02 03/02/21 15:02 RTMVY Rightmove $0.00 / + (+0.00%) Berenberg analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RTMVY Rightmove $0.00 / + (+0.00%) 02/24/21 Deutsche Bank Rightmove price target raised to 600 GBp from 540 GBp at Deutsche Bank 02/04/21 UBS Rightmove price target raised to 630 GBp from 620 GBp at UBS 01/29/21 Barclays Rightmove price target lowered to 550 GBp from 575 GBp at Barclays 01/20/21 BofA Rightmove downgraded to Underperform from Neutral at BofA

Recommendations	Rational price target raised to EUR 625 from EUR 620 at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 RTLLF Rational $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RTLLF Rational $0.00 / + (+0.00%) 01/29/21 Deutsche Bank Rational downgraded to Sell from Hold at Deutsche Bank 01/19/21 Berenberg Rational price target raised to EUR 620 from EUR 610 at Berenberg 10/29/20 HSBC Rational downgraded to Reduce from Hold at HSBC 09/15/20 Berenberg Rational downgraded to Hold from Buy at Berenberg
Recommendations	Klepierre price target raised to EUR 23 from EUR 18.50 at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 KLPEF Klepierre $0.00 / + (+0.00%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KLPEF Klepierre $0.00 / + (+0.00%) 02/18/21 Deutsche Bank Klepierre price target lowered to EUR 20 from EUR 21.50 at Deutsche Bank 01/22/21 Deutsche Bank Klepierre price target lowered to EUR 21.50 from EUR 23 at Deutsche Bank 01/18/21 BofA Klepierre downgraded to Underperform from Neutral at BofA 01/15/21 JPMorgan Klepierre price target lowered to EUR 20 from EUR 22 at JPMorgan
Recommendations	IAG price target raised to 230 GBp from 190 GBp at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 ICAGY IAG $0.00 / + (+0.00%) Berenberg analyst Adrian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 03/01/21 Peel Hunt IAG upgraded to Buy from Hold at Peel Hunt 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 01/27/21 Berenberg IAG price target raised to 190 GBp from 180 GBp at Berenberg 01/22/21 Kepler Cheuvreux IAG downgraded to Reduce from Hold at Kepler Cheuvreux ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Recommendations	Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg » 15:00 03/02/21 03/02 15:00 03/02/21 15:00 FMS Fresenius Medical $35.31 / +0.26 (+0.74%) Berenberg analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 02/10/21 Model N discloses J&J agreed to transition to its Revenue Cloud for Life Science 01/19/21 CytoSorb approved in Korea for all EU approved indications FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 02/26/21 JPMorgan Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan 02/24/21 Truist Fresenius Medical cut to Hold at Truist on more difficult operating backdrop 02/24/21 Truist Fresenius Medical downgraded to Hold from Buy at Truist 02/17/21 UBS Fresenius Medical price target lowered to EUR 72 from EUR 94 at UBS FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 00:00 Today 2021 London Global Healthcare Virtual Conference
Options	Callapalozza in Rocket Mortage echoes Gamestop squeeze » 15:00 03/02/21 03/02 15:00 03/02/21 15:00 RKT Rocket Companies $37.99 / +13.69 (+56.34%) Callapalozza in Rocket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $37.99 / +13.69 (+56.34%) 14:32 Today Rocket Companies soars as short interest gets highlighted 14:16 Today Rocket resumes trading after volatility halt, shares up 57% to $38.07 14:15 Today Rocket Companies trading resumes 14:10 Today Rocket Companies trading halted, volatility trading pause RKT Rocket Companies $37.99 / +13.69 (+56.34%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $37.99 / +13.69 (+56.34%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $37.99 / +13.69 (+56.34%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $37.99 / +13.69 (+56.34%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $37.99 / +13.69 (+56.34%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

ENTA
Today at 16:00

Enanta Pharmaceuticals, Inc. Firm Sponsored Meetings
ROST
Today at 16:15

Ross Stores - ROST Conference Calls
BGS
Today at 16:30

B&G Foods - BGS Conference Calls
AMBA
Today at 16:30

Ambarella - AMBA Conference Calls
RIGL
Today at 16:30

Rigel Pharmaceuticals - RIGL Conference Calls
LUNG
Today at 16:30

Pulmonx - LUNG Conference Calls
QTRX
Today at 16:30

Quanterix - QTRX Conference Calls
TMDX
Today at 16:30

TransMedics - TMDX Conference Calls
VXRT
Today at 16:30

Vaxart - VXRT Conference Calls
VEC
Today at 16:30

Vectrus - VEC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

SVB Leerink bullish on Myovant Sciences, initiates with an Outperform

TODAY'S FREE FLY STORIES

Get Full Fly Access